Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Radical changes in China's anti-COVID policy: What to expect now?

Published 10/12/2022, 12:10 am
Updated 10/12/2022, 12:10 am
© Reuters

© Reuters

By Laura Sánchez

Investing.com - Asian stock markets - Nikkei, Shanghai Composite, Hang Seng - are celebrating as China relaxes its strict anti-COVID measures and withdraws mandatory diagnostic tests from some public places, a shift in strategy that is getting experts talking.

China’s response to COVID-19 should now focus on preventing serious cases – rather than infection – by expanding vaccination, leading infectious disease expert Zhong Nanshan said Friday, according to the South China Morning Post.

"We cannot adopt the same strategy as two years ago," Zhong added.

"Among investors, the idea is spreading that the radical change adopted by Chinese authorities in their strategy to combat COVID-19, accelerating the reopening process, will lead to a sharp increase in cases in the coming weeks which will weigh on the country's economic growth in the short term," analysts at Link Securities noted.

"Thus, it is expected that China will still take a few months to adapt its society and economy to coexist with the virus, as the vast majority of countries have already done," they added.

"In the medium and long term, we understand that the change of strategy was absolutely necessary and, together with the expansive monetary and fiscal policies that are going to be implemented in China, will help the country to recover the path of economic growth, something that will be positive for many European companies with high exposure to the country, although we understand that it will make the fight against inflation more difficult, as demand for many goods will increase strongly, which will put upward pressure on prices," the analysts concluded.

"These measures are much welcome for an economy that has been severely battered this year," said Ting Lu, chief China economist at Nomura, in statements picked up by CNBC.

"However, we would also caution that the road to full reopening may still be gradual, painful, and bumpy," the expert added.

According to Renta 4, "Inflation levels are contained and far removed from developed economies which facilitates the adoption of new monetary and fiscal stimuli in the event that the Chinese economy requires it, something quite likely in an exit from the zero-COVID policy that seems slow and complicated (increase in the number of contagions before the lifting of restrictions)."

Daily COVID infections in mainland China, mostly asymptomatic, reached a record high of more than 40,000 in late November. Since then, the number has declined as cities reduced virus testing requirements.

The path forward for China to reopen may take a few months, with a surge in infections likely, noted Goldman Sachs, as echoed by CNBC.

(Translated from Spanish)

Latest comments

good idea
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.